Results 81 to 90 of about 3,249 (159)

A new NCL-targeting aptamer-drug conjugate as a promising therapy against esophageal cancer

open access: yesJournal of Nanobiotechnology
Esophageal cancer (EC) is one of the most common highly malignant tumors of the digestive system, with a poor prognosis under current treatment regimens.
Xue Zheng   +4 more
doaj   +1 more source

Abstract 3642: AS1411 causes a specific increase in levels of cell surface nucleolin in responsive cell lines

open access: yes, 2010
AS1411 is a 26-mer guanine-rich oligodeoxynucleotide that has antiproliferative activity against many types of cancer cells, but not against normal cells. It is currently being tested as an anticancer agent in Phase II clinical trials.
David Jones   +3 more
core   +1 more source

Investigating the mechanism of novel anticancer agent, AS1411 : does metabolism to guanine play a role? [PDF]

open access: yes, 2017
AS1411 is an oligonucleotide that has shown promising results in lab experiments and clinical trials as an anti-cancer drug, Likewise, treatments with guanine based purine compounds (GBPCs) have demonstrated similar anti-proliferative effects in vitro ...
Howard, Parker T, Parker T Howard
core   +1 more source

General cell-binding activity of intramolecular G-quadruplexes with parallel structure.

open access: yesPLoS ONE, 2013
G-quadruplexes (G4s) are four-stranded nucleic acid structures adopted by some repetitive guanine-rich sequences. Putative G-quadruplex-forming sequences (PQSs) are highly prevalent in human genome.
Tianjun Chang   +7 more
doaj   +1 more source

In silico activity of AS1411 aptamer against nucleolin of cancer cells

open access: yes, 2020
Background: It has been expected that AS1411 aptamer could work against the cancer cells. Although the general information is available, there is still lack of details for the purpose.
Farahbakhsh, Z.   +4 more
core  

Nucleolin Targeting AS1411 Modified Protein Nanoparticle for Antitumor Drugs Delivery

open access: yes, 2016
Over recent years, cell surface nucleolin as an anticancer target has attracted many researchers’ attentions. To improve the antitumor efficacy, we developed a nucleolin targeted protein nanoparticle (NTPN) delivery system in which human serum albumin ...
Chenchen Song (1441627)   +5 more
core   +1 more source

Growth inhibition of Huh7 by treatment with AS1411.

open access: yes, 2015
(a) Huh7 was incubated with AS1411 at concentrations from 1 μM to 10 μM for 2 days at 37°C then subjected to MTS assay. (b) Cell cycle arrest was tested by flow cytometry of PI-stained cells.
Chen Liu (75209)   +7 more
core   +1 more source

As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy

open access: yesCancer Nanotechnology
Background The utilization of liposomes in drug delivery has garnered significant attention due to their efficient drug loading capacity and excellent biocompatibility, rendering them a promising platform for tumor therapy.
Danhuan Zhang   +6 more
doaj   +1 more source

Multifunctional Theranostic Nanoparticles for Enhanced Tumor Targeted Imaging and Synergistic FUS/Chemotherapy on Murine 4T1 Breast Cancer Cell

open access: yesInternational Journal of Nanomedicine, 2022
Zhengyue Kang,1,2,* Min Yang,1,2,* Xiaoling Feng,1,2 Hongjian Liao,1,2 Zhifei Zhang,1,2 Yonghong Du1,2 1State Key Laboratory of Ultrasound in Medicine and Engineering, College of Biomedical Engineering, Chongqing Medical University, Chongqing ...
Kang Z   +5 more
doaj  

Activités biologiques de l'aptamère nucléoline AS1411 associé à nanosphères d'or : de la synthèse aux études mécanistiques

open access: yes, 2019
Un oligonucléotide riche en G, AS1411, interagi avec la nucléoline et inhibe la prolifération des cellules cancéreuses et la croissance tumorale. Cette action antiproliférative est augmentée lorsqu’AS1411 est conjugué à différents types de nanoparticules.
Kabirian Dehkordi, Samaneh
core  

Home - About - Disclaimer - Privacy